April 10, 2014 — Dose-escalated intensity-modulated radiation therapy (IMRT) with use of a moderate hypofractionation regimen (72 Gy in 2.4 Gy fractions) can safely treat patients with localized prostate cancer with limited grade 2 or 3 late toxicity, according to a study published in the April 1, 2014, edition of the International Journal of Radiation Oncology ? Biology ? Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO).
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now